Seong-Chul Kim
Directeur/Membre du Conseil chez KPS CORPORATION
Fortune : 3 M $ au 31/05/2024
Postes actifs de Seong-Chul Kim
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KPS CORPORATION | Directeur/Membre du Conseil | - | - |
Historique de carrière de Seong-Chul Kim
Anciens postes connus de Seong-Chul Kim
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
LSK Investment Co. Ltd.
 LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Directeur Général | 11/04/2016 | 31/12/2018 |
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - | |
| Fondateur | 01/01/2005 | - | |
| President | 01/01/2005 | - | |
| HLB CO., LTD. | Directeur/Membre du Conseil | - | - |
| Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Corée du Sud | 3 |
| Etats-Unis | 2 |
| 2 |
Opérationnelle
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HLB CO., LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
LSK Investment Co. Ltd.
LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Finance |
| KPS Corp. (South Korea) |
- Bourse
- Insiders
- Seong-Chul Kim
- Expérience
